Abstract
For centuries, man has looked toward nature as a means to ameliorate a plethora of health conditions. Natural products (NPs), in particular those from plants, have proven to be a vital source of pharmaceuticals as in the case of the well-established anticancer drug, paclitaxel and the emerging ginsenoside triterpenoids. However, plant sources of high-value NPs can often be slow growing and are rarely domesticated and the target molecules are typically found in only low concentrations. Numerous strategies have been implemented for the production of these high-value molecules, including natural harvest from the source plant, total chemical synthesis or semi-synthesis from a more abundant precursor. Currently, plant cell culture arguably offers the most sustainable, robust, controllable and environmentally friendly platform to produce NPs for the pharmaceutical industry. In this context, the isolation of cambial meristematic cells (CMCs) and their potential utility to produce key anticancer drugs may serve to overcome some of the limitations previously associated with production of pharmaceuticals from traditional dedifferentiated plant cells (DDCs).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ajikumar PK, Xiao W-H, Tyo KEJ, Wang Y, Simeon F, Leonard E et al (2010) Isoprenoid pathway optimization for taxol precursor overproduction in Escherichia coli. Science 330(6000):70–74
Amin A, Gali-Muhtasib H, Ocker M, Schneider-Stock R (2009) Overview of major classes of plant-derived anticancer drugs. Int J Biomed Sci 5(1):1–11
Bhojwani SS, Dantu PK (2013) Production of industrial phytochemicals. In: Plant tissue culture: an introductory text, 1st ed. Springer India. pp 275–286
Chankova SG, Dimova E, Dimitrova M, Bryant PE (2007) Induction of DNA double-strand breaks by zeocin in Chlamydomonas reinhardtii and the role of increased DNA double-strand breaks rejoining in the formation of an adaptive response. Radiat Environ Biophys 46(4):409–416
Cragg GM, Newman DJ (2005) Plants as a source of anti-cancer agents. J Ethnopharmacol 100(1–2):72–79
Cragg GM, Newman DJ (2013) Natural products: a continuing source of novel drug leads. Biochim Biophys Acta 1830(6):3670–3695
Cragg PGM, Boyd MR, Schepartz SA (1995) Pharmaceutical prospecting and the potential for pharmaceutical crops. Natural product drug discovery and development at the United States National Cancer Institute. Ann Mo Bot Gard 82:47–53
Cusido RM, Onrubia M, Sabater-Jara AB, Moyano E, Bonfill M, Goossens A et al (2014) A rational approach to improving the biotechnological production of taxanes in plant cell cultures of Taxus spp. Biotechnol Adv 32(6):1157–1167
Davies KM, Deroles SC (2014) Prospects for the use of plant cell cultures in food biotechnology. Curr Opin Biotechnol 26:133–140
DeJong JM, Liu Y, Bollon AP, Long RM, Jennewein S, Williams D et al (2006) Genetic engineering of taxol biosynthetic genes in Saccharomyces cerevisiae. Biotechnol Bioeng 93(5):212–224
Dias DA, Urban S, Roessner U (2012) A historical overview of natural products in drug discovery. Metabolites 2(2):303–336
Engels B, Dahm P, Jennewein S (2008) Metabolic engineering of taxadiene biosynthesis in yeast as a first step towards taxol (paclitaxel) production. Metab Eng 10(3–4):201–206
Expósito O, Bonfill M, Moyano E, Onrubia M, Mirjalili MH, Cusidó RM et al (2009) Biotechnological production of taxol and related taxoids: current state and prospects. Anti Cancer Agents Med Chem 9(1):109–121
Fiehn O (2002) Metabolomics—the link between genotypes and phenotypes. Plant Mol Biol 48(1–2):155–171
Fisher K, Turner S (2007) PXY, a receptor-like kinase essential for maintaining polarity during plant vascular-tissue development. Curr Biol 17(12):1061–1066
Frankenstein C, Eckstein D, Schmitt U (2005) The onset of cambium activity—a matter of agreement? Dendrochronologia 23(1):57–62
Fulcher N, Sablowski R (2009) Hypersensitivity to DNA damage in plant stem cell niches. Proc Natl Acad Sci U S A 106(49):20984–20988
Grafi G, Ben-Meir H, Avivi Y, Moshe M, Dahan Y, Zemach A (2007) Histone methylation controls telomerase-independent telomere lengthening in cells undergoing dedifferentiation. Dev Biol 306(2):838–846
Guo BH, Kai GY, Jin HB, Tang KX (2006) Taxol synthesis. Afr J Biotechnol 5:15–20
He L, Jagtap PG, Kingston DGI, Shen H-J, Orr GA, Horwitz SB (2000) A common Pharmacophore for taxol and the Epothilones based on the biological activity of a taxane molecule lacking a C-13 side chain. Biochemistry 39(14):3972–3978
Holton R, Somoza A, Kim C, Liang HB, Biediger F, Boatman RJ, Shindo PD, Smith M, Kim CC, First S (1994a) Total synthesis of taxol. 2. Completion of the C and D rings. J Am Chem Soc 116(4):1599–1600
Holton R, Somoza A, Kim C, Liang HB, Biediger F, Boatman RJ, Shindo PD, Smith M, Kim CC, First S (1994b) Total synthesis of taxol. 1. Functionalization of the B ring. J Am Chem Soc 116(4):1597–1598
Howat S, Park B, Oh IS, Jin Y-W, Lee E-K, Loake GJ (2014) Paclitaxel: biosynthesis, production and future prospects. New Biotechnol 31(3):242–245
Huang Q, Roessner CA, Croteau R, Scott AI (2001) Engineering Escherichia coli for the synthesis of taxadiene, a key intermediate in the biosynthesis of taxol. Bioorg Med Chem 9(9):2237–2242
Joshi JB, Elias CB, Patole MS (1996) Role of hydrodynamic shear in the cultivation of animal, plant and microbial cells. Chem Eng J Biochem Eng J 62(2):121–141
Keum Y-S, Park K-K, Lee J-M, Chun K-S, Park JH, Lee SK et al (2000) Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng. Cancer Lett 150(1):41–48
Kingston DGI (2000) Recent advances in the chemistry of taxol. J Nat Prod 63:726–734
Kolewe ME, Gaurav V, Roberts SC (2008) Pharmaceutically active natural product synthesis and supply via plant cell culture technology. Mol Pharm 5(2):243–256
Lee E-K, Jin Y-W, Park JH, Yoo YM, Hong SM, Amir R et al (2010) Cultured cambial meristematic cells as a source of plant natural products. Nat Biotechnol 28(11):1213–1217
Leung KW, Wong AS-T (2010) Pharmacology of ginsenosides: a literature review. Chin Med 5:20
Malik S, Cusidó RM, Mirjalili MH, Moyano E, Palazón J, Bonfill M (2011) Production of the anticancer drug taxol in Taxus baccata suspension cultures: a review. Process Biochem 46(1):23–34
Malik S, Hossein Mirjalili M, Fett-Neto AG, Mazzafera P, Bonfill M (2012) Living between two worlds: two-phase culture systems for producing plant secondary metabolites. Crit Rev Biotechnol 33:1–22
Manfredi JJ, Parness J, Horwitz SB (1982) Taxol binds to cellular microtubules. J Cell Biol 94:688–696
Miresmailli S, Isman MB (2014) Botanical insecticides inspired by plant-herbivore chemical interactions. Trends Plant Sci 19(1):29–35
Mirjalili N, Linden JC (1996) Methyl Jasmonate induced production of taxol in suspension cultures of Taxus cuspidata: ethylene interaction and induction models. Biotechnol Prog Am Chem Soc 12(1):110–118
Moon SH, Venkatesh J, Yu JW, Park SW (2015) Differential induction of meristematic stem cells of Catharanthus roseus and their characterization. Comp Rend Biol Acad Sci 338(11):745–756
Mountford PG (2010) The taxol® story–development of a green synthesis via plant cell fermentation. In: Green chemistry in the pharmaceutical industry, pp 145–160
Naill MC, Roberts SC (2004) Preparation of single cells from aggregated Taxus suspension cultures for population analysis. Biotechnol Bioeng 86(7):817–826
Newman DJ, Cragg GM (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70(3):461–477
Newman DJ, Cragg GM (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75(3):311–335
Nicolaou KC, Yang Z, Liu JJ, Ueno H, Nantermet PG, Guy RK et al (1994) Total synthesis of taxol. Nature 367(6464):630–634
Nosov AM (2012) Application of cell technologies for production of plant-derived bioactive substances of plant origin. Appl Biochem Microbiol 48(7):609–624
Ochoa-Villarreal M, Howat S, Jang MO, Kim IS, Jin Y-W, Lee E-K et al (2015) Cambial meristematic cells: a platform for the production of plant natural products. New Biotechnol 32(6):581–587
Ochoa-Villarreal M, Howat S, Hong S, Jang MO, Jin Y-W, Lee E-K et al (2016) Plant cell culture strategies for the production of natural products. BMB Rep 49(3):149–158
Oksman-Caldentey K-M, Inzé D (2004) Plant cell factories in the post-genomic era: new ways to produce designer secondary metabolites. Trends Plant Sci 9(9):433–440
Pasquali G, Porto DD, Fett-Neto AG (2006) Metabolic engineering of cell cultures versus whole plant complexity in production of bioactive monoterpene indole alkaloids: recent progress related to old dilemma. J Biosci Bioeng 101(4):287–296
Patel RN (1998) Tour de paclitaxel: biocatalysis for semisynthesis. Annu Rev Microbiol 52:361–395
Pauwels L, Inzé D, Goossens A (2009) Jasmonate-inducible gene: what does it mean? Trends Plant Sci 14(2):87–91
Pi Y, Jiang K, Hou R, Gong Y, Lin J, Sun X et al (2010) Examination of camptothecin and 10-hydroxycamptothecin in Camptotheca acuminata plant and cell culture, and the affected yields under several cell culture treatments. Biocell 34(3):139–143
Rao SR, Ravishankar GA (2002) Plant cell cultures: chemical factories of secondary metabolites. Biotechnol Adv 20(2):101–153
Roberts SC (2007) Production and engineering of terpenoids in plant cell culture. Nat Chem Biol 3(7):387–395
Sabater-Jara AB, Tudela LR, López-Pérez AJ (2010) In vitro culture of Taxus sp.: strategies to increase cell growth and taxoid production. Phytochem Rev 9(2):343–356
Schiff PB, Horwitz SB (1980) Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci U S A 77(3):1561–1565
Strobel GA, Stierle A, Hess WM (1993) Taxol formation in yew—Taxus. Plant Sci 92(1):1–12
Sugimoto K, Jiao Y, Meyerowitz EM (2010) Arabidopsis regeneration from multiple tissues occurs via a root development pathway. Dev Cell 18(3):463–471
Tabata H (2006) Production of paclitaxel and the related taxanes by cell suspension cultures of Taxus species. Curr Drug Targets 7(4):453–461
Thorpe T (2012) History of plant cell culture. In: Loyola-Vargas VM, Ochoa-Alejo N (eds) Methods in molecular biology, vol 877. Humana Press, Totowa, NJ, pp 169–180
Vongpaseuth K, Roberts SC (2007) Advancements in the understanding of paclitaxel metabolism in tissue culture. Curr Pharm Biotechnol 8(4):219–236
Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT (1971) Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93(9):2325–2327
Wilson SA, Roberts SC (2012) Recent advances towards development and commercialization of plant cell culture processes for the synthesis of biomolecules. Plant Biotechnol J 10(3):249–268
Wilson SA, Roberts SC (2014) Metabolic engineering approaches for production of biochemicals in food and medicinal plants. Curr Opin Biotechnol 26:174–182
Wu S, Chappell J (2008) Metabolic engineering of natural products in plants; tools of the trade and challenges for the future. Curr Opin Biotechnol 19(2):145–152
Xu J, Ge X, Dolan MC (2011) Towards high-yield production of pharmaceutical proteins with plant cell suspension cultures. Biotechnol Adv 29(3):278–299
Ye Z-H (2002) Vascular tissue differentiation and pattern formation in plants. Annu Rev Plant Biol 53:183–202
Yokoshima S, Ueda T, Kobayashi S, Sato A, Kuboyama T, Tokuyama H et al (2002) Stereocontrolled total synthesis of (+)-vinblastine. J Am Chem Soc 124(10):2137–2139
Yousefzadi M, Sharifi M, Behmanesh M, Moyano E, Bonfill M, Cusido RM et al (2010) Podophyllotoxin: current approaches to its biotechnological production and future challenges. Eng Life Sci 10(4):281–292
Acknowledgments
M.O.V. is supported by a scholarship from CONACYT, Mexico.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Loake, V.I.P., Ochoa-Villarreal, M. (2017). Cambial Meristematic Cells: A Sustainable Platform for the Production of Plant-Derived Anticancer Drugs. In: Malik, S. (eds) Biotechnology and Production of Anti-Cancer Compounds . Springer, Cham. https://doi.org/10.1007/978-3-319-53880-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-53880-8_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-53879-2
Online ISBN: 978-3-319-53880-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)